Studio Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
VCM
VPM
Studio Investment Management's ZBH Position: Q1 2026 in Review
Studio Investment Management increased its Zimmer Biomet (ZBH) stake by 13% in Q1 2026, buying an estimated $217K and bringing the position to 21,295 shares worth $1.93M. The position accounts for 0.35% of the portfolio, ranked #56.
Studio Investment Management first reported a position in ZBH in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.06M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Studio Investment Management held 21,295 shares of Zimmer Biomet worth $1.93M as of Q1 2026.
- Studio Investment Management bought 2,368 Zimmer Biomet shares in Q1 2026, an estimated $217K.
- Zimmer Biomet made up 0.35% of Studio Investment Management's portfolio in Q1 2026, its #56 holding.
- Studio Investment Management first reported a position in Zimmer Biomet in Q3 2021 and has held it in 19 quarters since.
- Studio Investment Management's Zimmer Biomet position peaked at $2.06M in Q1 2025.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Studio Investment Management's 13F filing for Q1 2026, filed 5 May 2026.